Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Bastide le Confort Medical ( (FR:BLC) ) has issued an announcement.
Bastide Group has expanded its operations in Canada by obtaining authorization to operate in respiratory assistance in British Columbia, which could lead to a significant increase in revenue. Additionally, Bastide has sold its French subsidiary CICA PLUS, which was underperforming financially, as part of its strategy to divest low-growth assets and focus on reducing debt.
More about Bastide le Confort Medical
The Bastide Group, founded in 1977, is a leading European home health care provider operating in eight countries. It specializes in medical devices and services across various health areas including diabetes, nutrition, infusion, respiratory, stomatherapy, and urology. The company is listed on Euronext Paris.
YTD Price Performance: -4.55%
Average Trading Volume: 156
Technical Sentiment Consensus Rating: Sell
Current Market Cap: €171M
For detailed information about BLC stock, go to TipRanks’ Stock Analysis page.